Immuron (IMRN)
Immuron Limited, a biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, the United Stat...
- Open
- 1.810
- High
- 1.990
- Low
- 1.540
- Prev. Close
- 1.110
- Volume
- 123.14M
- Turnover
- 217.44M
- Avg Price
- 1.766
- Bid/Ask Ratio
- --
- Amplitude
- 40.54%
- 52wk High
- 2.390
- Volume Ratio
- 3,554.24
- Turnover Ratio
- 1,559.76%
Immuron Analyst Rating
View moreForecast & Rating
Apr 22, 2026Price forecast
$3.98121.32%
Forecast & RatingBuy
1analysts
- Strong buy0.00%
- Buy100.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- US Stock Market Update · 1 day ago, 10:10 PM
Immuron surges 62% on Calmino PROIBS device US distribution deal
- US Stock Market Update · 1 day ago, 07:49 PM
Immuron soars 57% on exclusive US distribution deal for digestive device PROIBS
- US Stock Market Update · 1 day ago, 05:55 PM
Immuron soars nearly 50% in regular trading on US deal for PROIBS
- benzinga_article · 1 day ago, 05:06 PM
12 Health Care Stocks Moving In Friday's Intraday Session
- benzinga_article · 2 days ago, 03:31 AM
American Outdoor Brands (AOUT) Stock Jumps Over 25% After Hours: Why Is It Trending
- US Stock Market Update · 1 day ago, 03:46 PM
Immuron Soars 51% After Exclusive US Distribution Deal With Calmino
